Cargando…

Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?

Crohn’s Disease (CD) results from inappropriate response toward commensal flora. Earlier studies described CD as a Th1 mediated disease. Current models view both phenotypes as a continuum of various permutations between Th1, Th2 and Th17 pathways compounded by a range of Treg disfunctions. In the pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lo, Wing-Cheong, Arsenescu, Violeta, Arsenescu, Razvan I., Friedman, Avner
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100971/ https://www.ncbi.nlm.nih.gov/pubmed/27824890 http://dx.doi.org/10.1371/journal.pone.0165782

Ejemplares similares

Substance P Mediates Proinflammatory Cytokine Release From Mesenteric Adipocytes in Inflammatory Bowel Disease Patients
por: Sideri, Aristea, et al.
Publicado: (2015)

Autoimmune enteropathy with a CD8(+ )CD7(- )T-cell small bowel intraepithelial lymphocytosis: case report and literature review
por: Bishu, Shrinivas, et al.
Publicado: (2011)

Polychlorinated Biphenyl-77 Induces Adipocyte Differentiation and Proinflammatory Adipokines and Promotes Obesity and Atherosclerosis
por: Arsenescu, Violeta, et al.
Publicado: (2008)

Correction: Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?
Publicado: (2017)

Cytomegalovirus-Related Hospitalization Is Associated With Adverse Outcomes and Increased Health-Care Resource Utilization in Inflammatory Bowel Disease
por: Zhang, Cheng, et al.
Publicado: (2016)

Adipose Tissue Immune Response: Novel Triggers and Consequences for Chronic Inflammatory Conditions
por: Ghigliotti, Giorgio, et al.
Publicado: (2014)

Intestinal Epithelial Serum Amyloid A Modulates Bacterial Growth In Vitro and Pro-Inflammatory Responses in Mouse Experimental Colitis
por: Eckhardt, Erik RM, et al.
Publicado: (2010)

Anti-TNF-α Therapy Suppresses Proinflammatory Activities of Mucosal Neutrophils in Inflammatory Bowel Disease
por: Zhang, Cui, et al.
Publicado: (2018)

Vedolizumab Concentrations in Breast Milk: Results from a Prospective, Postmarketing, Milk-Only Lactation Study in Nursing Mothers with Inflammatory Bowel Disease
por: Sun, Wan, et al.
Publicado: (2021)

TILECAL Data Acquisition System for the ATLAS Test Beam Experiments
por: Arsenescu, R
Publicado: (1994)

Secondary particle yields from 450 GeV/c protons on beryllium, a precise measurement for present and future neutrino beam calculations
por: Arsenescu, R
Publicado: (1999)

Transmembrane TNF-α Density, but not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease
por: Amini Kadijani, Azade, et al.
Publicado: (2017)

Erratum: Transmembrane TNF-α Density, But Not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease
por: Amini Kadijani, Azade, et al.
Publicado: (2017)

TNF-α inhibitor reduces drug-resistance to anti-PD-1: A mathematical model
por: Lai, Xiulan, et al.
Publicado: (2020)

A guide to preparation of patients with inflammatory bowel diseases for anti-TNF-α therapy
por: Chebli, Júlio Maria Fonseca, et al.
Publicado: (2014)

IgA Nephropathy in the Setting of Anti-TNF-α Therapy for Inflammatory Bowel Disease
por: Strobel, Thomas, et al.
Publicado: (2020)

Anti-TNF Withdrawal in Inflammatory Bowel Disease
por: Torres, Joana, et al.
Publicado: (2016)

Myocardial strain imaging and malignant ventricular arrhythmia risk
por: Floria, Mariana, et al.
Publicado: (2016)

How could nanobiotechnology improve treatment outcomes of anti-TNF-α therapy in inflammatory bowel disease? Current knowledge, future directions
por: Eder, Piotr, et al.
Publicado: (2021)

Polymorphisms in PRKCDBP, a Transcriptional Target of TNF-α, Are Associated With Inflammatory Bowel Disease in Korean
por: Kim, Jung-Wook, et al.
Publicado: (2015)

Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease
por: Schneider, Anna-Maria, et al.
Publicado: (2018)

Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-α Treatment—A Review
por: Mihai, Ioana Ruxandra, et al.
Publicado: (2023)

Measurement of pion and kaon fluxes below 60 GeV/c produced by 450 GeV/c protons on a beryllium target
por: Ambrosini, G, et al.
Publicado: (1996)

Radioimmune Imaging of α(4)β(7) Integrin and TNFα for Diagnostic and Therapeutic Applications in Inflammatory Bowel Disease
por: Signore, Alberto, et al.
Publicado: (2023)

TNFα blockade prevents the development of inflammatory bowel disease in HLA-B27 transgenic rats
por: Milia, Anna Franca, et al.
Publicado: (2009)

Association of TNF-α -857 Polymorphism with Inflammatory Bowel Disease in a Group of Iranian Azeri Individuals
por: Rahbar Kafshboran, Haniyeh, et al.
Publicado: (2014)

Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study
por: Marin-Jimenez, Ignacio, et al.
Publicado: (2020)

Toward Point-of-Care Diagnostics to Monitor MMP-9 and TNF-α Levels in Inflammatory Bowel Disease
por: Liu, Dandan, et al.
Publicado: (2021)

Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
por: Park, Jihye, et al.
Publicado: (2022)

Loss of response to anti‐TNFα agents depends on treatment duration in patients with inflammatory bowel disease
por: Schultheiss, Johannes P. D., et al.
Publicado: (2021)

Author’s Reply
por: Ouatu, Anca, et al.
Publicado: (2016)

Early Sigmoidoscopy or Colonoscopy Is Associated With Improved Hospital Outcomes in Ulcerative Colitis-Related Hospitalization
por: Obi, Kenneth, et al.
Publicado: (2016)

TNF Blocking Therapies and Immunomonitoring in Patients with Inflammatory Bowel Disease
por: Altwegg, Romain, et al.
Publicado: (2014)

Anti‐TNF‐induced lupus in patients with inflammatory bowel disease
por: Picardo, Sherman, et al.
Publicado: (2019)

Coronary stent entrapment
por: Macovei, Liviu Gheorghe, et al.
Publicado: (2014)

FOXP3(+) T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNFα Agents
por: Guidi, Luisa, et al.
Publicado: (2013)

Mitral annular calcification: left atrial size and left ventricular dysfunction
por: Floria, Mariana, et al.
Publicado: (2016)

Pott’s Puffy Tumor in an Inflammatory Bowel Disease Patient on Anti-TNF Therapy
por: Miri, Ahmad, et al.
Publicado: (2021)

Articular manifestations in patients with inflammatory bowel diseases treated with anti-TNF
por: Cachen, Laurie, et al.
Publicado: (2022)

Asymptomatic polyvascular atherosclerotic disease requires a complex management strategy – case report and review of the literature
por: Jurcut, R, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_19q57tfdoajkguhduiio1ir7iu